ask="N/A"
ask_size="N/A"
average_daily_volume="248271"
bid="N/A"
bid_size="N/A"
book_value="3.42"
change="N/A"
change_from_200_day_moving_average="-0.18"
change_from_50_day_moving_average="0.29"
change_from_52_week_high="-4.50"
change_From_52_week_low="2.41"
change_in_percent="N/A"
close="8.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.07"
ebitda="-1.40M"
eps_estimate_current_year="-2.94"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-2.63"
ex_dividend_date="N/A"
float_shares="5020000"
high="N/A"
high_52_weeks="12.50"
last_trade_date="2/13/2017"
last_trade_price="8.00"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="5.59"
market_capitalization="97.30M"
moving_average_200_day="8.18"
moving_average_50_day="7.71"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.80"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.24%"
percent_change_from_50_day_moving_average="+3.74%"
percent_change_from_52_week_high="-36.00%"
percent_change_from_52_week_low="+43.11%"
previous_close="8.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.34"
price_per_sales="1.42"
revenue="68.73M"
shares_outstanding="12163000"
short_ratio="3.68"
stock_exchange="NCM"
symbol="REPH"
volume="0"
weeks_range_52="5.59 - 12.50"
